Devasia, A. J., Pai, A. A., Prakash, M. A., Lakshmi, K. M., Korula, A., Kulkarni, U., Aboobacker, F. N., Lionel, S., Selvarajan, S., Abraham, A., Srivastava, A., Mathews, V., Balasubramanian, P. and George, B MM-134 Comparable Toxicity and Outcomes With Generic and Innovator Melphalan in Myeloma Auto Transplants. Clinical Lymphoma, Myeloma and Leukemia; 2022, 22 S407

5 NOVEMBER 2021 | VOLUME 138, NUMBER Supplement 1

Kulkarni UP, Selvarajan S, Lionel S, Prakash MA, Palani HK, Balasundaram N, Venkataraman A, Korula A, Devasia AJ, Fouzia NA, Janet NB, Nair SC, Abraham A, Mani T, Lakshmanan J, Arunachalam AK, Balasubramanian P, George B, Mathews V. Real world data with concurrent retinoic acid and arsenic trioxide for the treatment of acute promyelocytic leukemia. Blood Cancer J. 2022 Jan 31;12(1):22. doi: 10.1038/s41408-022-00619-3. PMID: 35102152; PMCID: PMC8803919.

Devasia, A. J., Pai, A. A., Prakash, M. A., Lakshmi, K. M., Korula, A., Kulkarni, U., Aboobacker, F. N., Lionel, S., Selvarajan, S., Abraham, A., Srivastava, A., Mathews, V., Balasubramanian, P. and George, B MM-134 Comparable Toxicity and Outcomes With Generic and Innovator Melphalan in Myeloma Auto Transplants. Clinical Lymphoma, Myeloma and Leukemia; 2022, 22 S407

5 NOVEMBER 2021 | VOLUME 138, NUMBER Supplement 1

Kulkarni UP, Selvarajan S, Lionel S, Prakash MA, Palani HK, Balasundaram N, Venkataraman A, Korula A, Devasia AJ, Fouzia NA, Janet NB, Nair SC, Abraham A, Mani T, Lakshmanan J, Arunachalam AK, Balasubramanian P, George B, Mathews V. Real world data with concurrent retinoic acid and arsenic trioxide for the treatment of acute promyelocytic leukemia. Blood Cancer J. 2022 Jan 31;12(1):22. doi: 10.1038/s41408-022-00619-3. PMID: 35102152; PMCID: PMC8803919.